Cardiovascular Drugs and Therapy

August 2011, Volume 25, Issue 4, pp 365–366 | Cite as

Erratum to: Design and Rationale of Japanese Evaluation Between Formula of Azelnidipine and Amlodipine Add on Olmesartan to Get Antialbuminuric Effect Study (J-FLAG)

Evaluation of the Antialbuminuric Effects between Calcium Channel Blocker with Sympatholytic Action in Hypertensive Patients with Diabetes and Albuminuria

• Authors
• Authors and affiliations

• Katsuyuki Ando
• Masakazu Haneda
• Sadayoshi Ito
• Naoki Kashihara
• Koichi Node
• Masaomi Nangaku
• Tatsuo Shimosawa
• Junji Kishimoto
• Toshiro FujitaEmail author

Erratum

First Online: 07 July 2011

• 384 Downloads

Erratum to: Cardiovasc Drugs Ther

DOI 10.1007/s10557-011-6309-5

Figure:

The doses of azelnidipine in figure are not 2.5–5 mg/day but 8–16 mg/day as shown in the below.

Open image in new window

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

• Katsuyuki Ando
  • 1
• Masakazu Haneda
  • 3
• Sadayoshi Ito
  • 4
• Naoki Kashihara
  • 5
• Koichi Node
  • 6
• Masaomi Nangaku
  • 1
• Tatsuo Shimosawa
  • 2
• Junji Kishimoto
  • 7
• Toshiro Fujita
  • 1
  Email author

1. 1.Department of Nephrology and Endocrinology, Faculty of MedicineUniversity of TokyoTokyoJapan
2. 2.Department of Clinical Laboratory, Faculty of MedicineUniversity of TokyoTokyoJapan
3. 3.Division of Metabolism and Biosystemic Science, Department of MedicineAsahikawa Medical UniversityAsahikawaJapan
4. 4.Division of Nephrology, Endocrinology, and Vascular Medicine, Department of Internal MedicineTohoku University Graduate School of MedicineSendaiJapan
5. 5.Division of Nephrology, Department of Internal MedicineKawasaki Medical SchoolKurashikiJapan
6. 6.Department of Cardiovascular MedicineSaga UniversitySagaJapan
7. 7.Center for Clinical and Translational ResearchKyushu University HospitalFukuokaJapan